EMG
ENZ

Ellington Management Group’s Enzo Biochem, Inc. ENZ Stock Holding History

Ellington Management Group’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-10,900
Closed -$120K – 895
2017
Q2 		$120K Buy
+10,900
New +$102K 0.02% 588
2014
Q3 		– Sell
-21,600
Closed -$113K – 493
2014
Q2 		$113K Buy
+21,600
New +$93.4K 0.05% 405

Other funds holding ENZ

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ellington Management Group's ENZ Position: Q3 2017 in Review

Ellington Management Group sold out of Enzo Biochem, Inc. (ENZ) in Q3 2017, closing a stake of 10,900 shares — an estimated $120K sold.

Ellington Management Group first reported a position in ENZ in Q2 2014 and held it in 2 quarters. The position peaked at $120K in Q2 2017. 116 funds tracked by Wall St. Rank hold ENZ as of Q3 2017.

  • Ellington Management Group reported no remaining Enzo Biochem, Inc. position as of Q3 2017 after selling out during the quarter.
  • Ellington Management Group sold 10,900 Enzo Biochem, Inc. shares in Q3 2017, an estimated $120K.
  • Ellington Management Group first reported a position in Enzo Biochem, Inc. in Q2 2014 and held it in 2 quarters.
  • Ellington Management Group's Enzo Biochem, Inc. position peaked at $120K in Q2 2017.
  • 116 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2017.

Based on Ellington Management Group's 13F filing for Q3 2017, filed 14 Nov 2017.